IP Library › Granted Patent US 12,568,991
Granted Patent B2
US 12,568,991 · App. 17/307,917 · Granted Mar 10, 2026

Method for increasing the solubility and stability of organic compositions

Inventors: Gaurav Parekh (Twin Falls, ID); Brent L. Petersen (Twin Falls, ID)
Assignee: Glanbia Dairy Nutrition Limited
A23J7/00A23L29/273A23L29/281A23L33/155A23L33/175A23L33/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,568,991
App. No.
17/307,917
Granted
Mar 10, 2026
Kind
B2
Abstract

Disclosed is a method for making a shelf-stable organic compound in a more water-soluble form, the higher-solubility form being provided in liquid and/or powder. The method utilizes a surfactant solution comprising lecithin, water, and at least one polysaccharide into which at least one limited-solubility organic compound is admixed to form a dispersion.

Claims (13)

1 . An encapsulated dispersion composition comprising creatine monohydrate, lecithin, and at least one non-pectin, polysaccharide with a bound galacturonic acid value of at least about 6 g/100 g; wherein the composition has a chemical stability of about 30% after 12 months at an acidic pH; wherein the creatine monohydrate has a net concentration of 23.7-40.2 g/100 g as in dispersion; wherein the lecithin has a net concentration of 3.1-9.9 g/100 g as in dispersion; and wherein the polysaccharide has a net concentration of 4.9-10.2 g/100 g as in dispersion.

2 . The encapsulated dispersion composition of claim 1 further comprising at least one limited-solubility organic compound selected from the group consisting of ubiquinone, ubiquinol, menaquinone-7, Vitamin K2, choline, at least one curcuminoid, at least one flavonoid, at least one amino acid, at least one peptide, their derivatives, and combinations thereof.

3 . The encapsulated dispersion composition of claim 1 , further comprising at least one of a calcium salt or a magnesium salt.

4 . The encapsulated dispersion composition of claim 3 , wherein the composition comprises a calcium salt and the calcium salt is calcium chloride.

5 . The encapsulated dispersion composition of claim 1 , wherein the lecithin is derived from a plant source.

6 . The encapsulated dispersion composition of claim 5 , wherein the lecithin is selected from the group consisting of soy lecithin, sunflower lecithin, rape lecithin, and combinations thereof.

7 . The encapsulated dispersion composition of claim 1 , wherein the composition is a powder.

8 . An encapsulated dispersion composition comprising creatine monohydrate, lecithin, and at least one polysaccharide with a bound galacturonic acid value of less than about 6 g/100 g, wherein the polysaccharide is selected from the group consisting of maltodextrin, alpha cyclodextrin, and combinations thereof; and wherein the composition has a chemical stability of about 67% after 12 months at a neutral pH; wherein the creatine monohydrate has a net concentration of 23.7-40.2 g/100 g as in dispersion; wherein the lecithin has a net concentration of 3.1-9.9 g/100 g as in dispersion; and wherein the polysaccharide has a net concentration of 4.9-10.2 g/100 g as in dispersion.

9 . The encapsulated dispersion composition of claim 8 further comprising at least one limited-solubility organic compound selected from the group consisting of creatine, ubiquinone, ubiquinol, menaquinone-7, Vitamin K2, choline, at least one curcuminoid, at least one flavonoid, at least one amino acid, at least one peptide, their derivatives, and combinations thereof.

10 . The encapsulated dispersion composition of claim 8 , wherein the lecithin is derived from a plant source.

11 . The encapsulated dispersion composition of claim 10 , wherein the lecithin is selected from the group consisting of soy lecithin, sunflower lecithin, rape lecithin, and combinations thereof.

12 . The encapsulated dispersion composition of claim 8 , wherein the composition is a powder.

13 . The encapsulated dispersion composition of claim 12 , wherein the powder comprises about 61.2 g/100 g of the creatine monohydrate.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2025
From: GLANBIA NUTRITIONALS LIMITED
To: GLANBIA DAIRY NUTRITION LIMITED
Reel/Frame 073200/0723 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 67409 FRAME: 82. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 21, 2024
From: PAREKH, GAURAV; PETERSEN, BRENT L.
To: GLANBIA NUTRITIONALS (IRELAND) LTD.
Reel/Frame 067485/0080 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2024
From: PAREKH, GAURAV; PETERSEN, BRENT L.
To: GLANBIA NUTRITLONALS (IRELAND) LTD.
Reel/Frame 067409/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2023
From: GLANBIA NUTRITIONALS (IRELAND) LIMITED
To: GLANBIA NUTRITIONALS LIMITED
Reel/Frame 063616/0399 →
Continuity (4)
Continuation In Part 16164762 · Oct 18, 2018
Provisional Application 62726421 · Sep 3, 2018
Provisional Application 62573995 · Oct 18, 2017
Related Publication 20220053795A1 · Feb 24, 2022
References Cited (48)
US 4734401A · Blouin · 1988 [cited by examiner]
US 5929051A · Ni · 1999 [cited by examiner]
US 5968544A · Howard et al. · 1999 [cited by applicant]
US 6114379A · Wheelwright · 2000 [cited by examiner]
US 7432073B2 · Niwa et al. · 2008 [cited by applicant]
US 20010042936A1 · Kessel et al. · 2001 [cited by applicant]
US 20040013732A1 · Farber et al. · 2004 [cited by applicant]
US 20060151899A1 · Kato · 2006 [cited by examiner]
US 20070116836A1 · Prakash · 2007 [cited by examiner]
US 20080020995A1 · Purpura et al. · 2008 [cited by applicant]
US 20100055178A1 · Vilallobos · 2010 [cited by applicant]
US 20110251280A1 · Owoc · 2011 [cited by applicant]
US 20140066512A1 · O'Gorman · 2014 [cited by examiner]
US 20140105994A1 · Wu et al. · 2014 [cited by applicant]
US 20150238453A1 · Owoc · 2015 [cited by applicant]
US 20160120817A1 · Doherty · 2016 [cited by applicant]
US 20190230960A1 · Parekh et al. · 2019 [cited by applicant]
CN 2003026439A1 · 2003 [cited by applicant]
CN 101536993A · 2009 [cited by applicant]
CN 20100024657A · 2010 [cited by applicant]
CN 102908337A · 2013 [cited by applicant]
CN 103404854A · 2013 [cited by applicant]
CN 104432095A · 2015 [cited by applicant]
CN 105285159B · 2020 [cited by applicant]
KR 20080068671A · 2008 [cited by applicant]
Moura et al., “Characterization and physicochemical properties of pectins extracted from agroindustrial by-products”, J Food Science Technol, Aug. 2, 2017, 54(10):3111-3117. (Year: 2017). [cited by examiner]
Yin et al., “Influence of Pea Protein Aggregates on the Structure and Stability of Pea Protein/Soybean Polysaccharide Complex Emulsions”, Molecules 2015, 20, pp. 5165-5183; doi:10.3390/molecules20035165. (Year: 2015). [cited by examiner]
Brummer et al., “Structural and functional characteristics of dietary fibre in beans, lentils, peas and chickpeas”, Food Research International 67, 2015, pp. 117-125; Retrieved from Internet URL: https://doi.org/10.1016… [cited by examiner]
Alam, M, et al., “FDA-Approved Natural Polymers for Fast Dissolving Tablets”, Journal of Pharmaceutics, Article ID 952970, 6 pages (2014). [cited by applicant]
Davis, M, et al., “Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs”, Journal of Controlled Release 269, 110-127 (2018). [cited by applicant]
Debnath, S, et al., “A Review on Natural Binders used in Pharmacy”, Asian Journal of Pharmaceutical Research 9 (1), 55-60 (2019). [cited by applicant]
Incredible Egg, “Emulsification—American Egg Board”, https://www.incredibleegg.org/professionals/manufacturers/real-egg-functionality/emulsification, 3 pages, (2023). [cited by applicant]
Kelleher, J, et al., “A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products”, International Journal of Pharmaceuti… [cited by applicant]
Maniruzzaman, M, et al., “Hot-Melt Extrusion (HME): From Process to Pharmaceutical Applications”, Recent Advances in Novel Drug Carrier Systems, Chapter 1, 15 pages, http://dx.doi.org/10.5772/51582 (2012). [cited by applicant]
Mohammed, N, et al., “Spray Drying for the Encapsulation of Oils—A Review”, Molecules 25, 3873, 16 pages, doi:10.3390/molecules 25173873 (2020). [cited by applicant]
Ordoubadi, M, et al., “Mechanistic Formulation Design of Spray-Dried Powders”, KONA Powder and Particle Journal No. 40, 149-171 (2023). [cited by applicant]
Patil, H, et al., “Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation”, AAPS PharmSciTech 17 (1), 20-42 (2015). [cited by applicant]
Pharma Excipients, “Advantages and Disadvantages of Hot Melt Coating”, https://www.pharmaexcipients.com/coating/advantages-hot-melt-coating, 6 pages (2023). [cited by applicant]
Reno, C, et al., “Preparation and properties of α-tricalcium phosphate microspheres by spray drying”, Ceramica 65, 599-604 (2019). [cited by applicant]
Sandhu, H, et al., “Overview of Amorphous Solid Dispersion Technologies”, Advances in Delivery Science and Technology, DOI 10.1007/978-1-4939-1598-9_3, 91-122 (2014). [cited by applicant]
Singh, A, et al., “Characterizing the pH-Dependent Release Kinetics of Food-Grade Spray Drying Encapsulated Iron Microcapsules for Food Fortification”, Food Bioprocess Technol 11, 435-446 (2018). [cited by applicant]
Sosnik, A, et al., “Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers”, Advances in Colloid and Interface Science 223, 40-54 (2015). [cited by applicant]
Bird, S, “Creatine supplementation and exercise performance: a brief review”, Journal of Sports Science and Medicine 2, 123-132 (2003). [cited by applicant]
Database, “Aseptic Drink Packages”, Database accession No. 10086250, Mintel, 2 pages (2001). [cited by applicant]
Patent Cooperation Treaty, International Search Report and Written Opinion for PCT/US2018/056591, 8 pages, dated Dec. 21, 2018. [cited by applicant]
Caffall, K, et al., “The structure, function, and biosynthesis of plant cell wall pectic polysaccharides”, Carbohydrate Research 344, 1879-1900 (2009). [cited by applicant]
Wittkowski, Knut M., “The Effect of Alpha-Cyclodextrin on Postprandial Glucose Excursions: a Systematic Meta-Analysis”, Cureus vol. 14(11): e31160, 11 pgs (2002). [cited by applicant]
“Carbohydrates”, General Biology 1e (OpenStax), Unit I, Section 3.2, https://bio.libretexts.org/@go/page/1789, 12pgs (access date: Jun. 24, 2025). [cited by applicant]